Accelerated rTMS for Stimulant Use Disorder and Depression
This study is looking at an accelerated form of repetitive Transcranial Magnetic Stimulation (rTMS) for people with both depression and stimulant use disorder (like cocaine or methamphetamine use). rTMS is a treatment that uses magnetic fields to stimulate nerve cells in the brain. You would receive up to 50 rTMS sessions over three weeks, with each session lasting about 10 minutes and breaks in between. The main goal of this small study is to see if this accelerated rTMS treatment is practical and can be done effectively. We are looking for 40 participants aged 18-65 who use stimulants at least 10 days in the month before joining.
- Study design
- This is a small, open-label study, meaning both you and the study team will know what treatment you are receiving. It plans to include 40 participants.
- What's involved
- You would receive up to four rTMS sessions per day, five days a week, for a total of 50 sessions over three weeks. You would also have EEG (brain wave test), ECG (heart test), urine drug screens, and complete questionnaires.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will have a follow-up visit one week after your last rTMS session.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Accelerated rTMS for Substance Use Disorder and Depression
At a glance
Conditions
NCT06424184
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
UT Southwestern Medical Center
Dallas, Texasno site contact published
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Manish Jha, M.B.B.S · PRINCIPAL_INVESTIGATOR · University of Texas Southwestern Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Feasibility of an accelerated course of repetitive Transcranial Magnetic Stimulation (rTMS).3 weeks
Feasibility will be measured by completion of at least 30 out of 50 sessions of rTMS.